Obesity and Insulin Resistance

Obesity and insulin resistance are closely linked and contribute to the onset of type 2 diabetes and other metabolic disorders. This session will focus on the mechanisms that connect obesity and insulin resistance, with an emphasis on the latest research into their pathophysiology. Experts will explore how adipose tissue, inflammation, and insulin signaling contribute to the development of metabolic diseases.

Attendees will also learn about current and emerging therapeutic strategies to treat obesity and improve insulin sensitivity, including pharmacological interventions, lifestyle changes, and surgical options. Discussions will cover the challenges in managing these conditions, particularly in populations with high obesity rates, and how healthcare providers can improve treatment outcomes.

    Related Conference of Obesity and Insulin Resistance

    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 14-15, 2026

    7th World Summit on Diabetes

    Rome, Italy
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France
    June 22-23, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France

    Obesity and Insulin Resistance Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in